These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9124449)

  • 1. In vivo angiotensin II receptor blockade and converting enzyme inhibition on canine aortic viscoelasticity.
    Barra JG; Levenson J; Armentano RL; Cabrera Fischer EI; Pichel RH; Simon A
    Am J Physiol; 1997 Feb; 272(2 Pt 2):H859-68. PubMed ID: 9124449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventive effect of chronic converting enzyme inhibition on aortic stiffening induced by renovascular hypertension in conscious dogs.
    Fischer EI; Levenson J; Barra JG; Armentano RL; Pichel RH; Simon A
    Cardiovasc Res; 1993 Jun; 27(6):1039-44. PubMed ID: 8221761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between angiotensin receptor antagonism and converting enzyme inhibition in heart failure. Differential acute effects according to the renin-angiotensin system activation.
    Su J; Barbe F; Houël R; Guyene TT; Crozatier B; Hittinger L
    Basic Res Cardiol; 1999 Apr; 94(2):128-35. PubMed ID: 10326661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of chronic treatment with losartan and enalaprilat on [3H]-norepinephrine release from isolated atria of Wistar-Kyoto and spontaneously hypertensive rats.
    Foucart S; Patrick SK; Oster L; de Champlain J
    Am J Hypertens; 1996 Jan; 9(1):61-9. PubMed ID: 8834708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of captopril and losartan on blood pressure and accumulation of LDL and fibrinogen by aortic wall and other tissues in normotensive and hypertensive rats.
    Medina R; Cardona-Sanclemente LE; Born GV; Brown MJ
    J Cardiovasc Pharmacol; 1997 Jan; 29(1):125-9. PubMed ID: 9007681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diastolic properties in canine hypertensive left ventricular hypertrophy: effects of angiotensin converting enzyme inhibition and angiotensin II type-1 receptor blockade.
    Hayashida W; Donckier J; Van Mechelen H; Charlier AA; Pouleur H
    Cardiovasc Res; 1997 Jan; 33(1):54-62. PubMed ID: 9059528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic and coronary effects of the angiotensin II receptor antagonist EXP3174 in dogs.
    Richard V; Berdeaux A; Giudicelli JF
    J Cardiovasc Pharmacol; 1993 Jul; 22(1):52-7. PubMed ID: 7690096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of angiotensin II receptor blockade on the interaction between enalaprilat and doxazosin in rat tail arteries.
    Marwood JF
    Clin Exp Pharmacol Physiol; 1998; 25(7-8):517-21. PubMed ID: 9673422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
    Murakami M; Suzuki H; Naitoh M; Matsumoto A; Kageyama Y; Tsujimoto G; Saruta T
    J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemodynamic effects of an angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist during hypovolaemia in the anaesthetized pig.
    Ryckwaert F; Colson P; André E; Perrigault PF; Guillon G; Barberis C
    Br J Anaesth; 2002 Oct; 89(4):599-604. PubMed ID: 12393362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of oral losartan and enalapril on local venous and systemic pressor responses to angiotensin I and II in healthy men.
    Goldberg MR; de Mey C; Wroblewski JM; Li Q; Schroeter V; Belz GG
    Clin Pharmacol Ther; 1996 Jan; 59(1):72-82. PubMed ID: 8549037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arterial effects of angiotensin converting enzyme inhibition in renovascular and spontaneously hypertensive rats.
    Levy BI; Michel JB; Salzmann JL; Azizi M; Poitevin P; Camilleri JP; Safar ME
    J Hypertens Suppl; 1988 Dec; 6(3):S23-5. PubMed ID: 3225686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of antihypertensive drugs on peritoneal vessels in hypertensive dogs with mild renal insufficiency.
    Ishida Y; Tomori K; Nakamoto H; Imai H; Suzuki H
    Adv Perit Dial; 2003; 19():10-4. PubMed ID: 14763026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of angiotensin II receptor AT1 subtypes in renal afferent arterioles during chronic changes in sodium diet.
    Ruan X; Wagner C; Chatziantoniou C; Kurtz A; Arendshorst WJ
    J Clin Invest; 1997 Mar; 99(5):1072-81. PubMed ID: 9062366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue angiotensin II and endothelin-1 modulate differently the response to flow in mesenteric resistance arteries of normotensive and spontaneously hypertensive rats.
    Matrougui K; Lévy BI; Henrion D
    Br J Pharmacol; 2000 Jun; 130(3):521-6. PubMed ID: 10821779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hormonal contribution to short-term variability of blood pressure in a renovascular hypertension model].
    Ponchon P; Elghozi JL
    Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1203-7. PubMed ID: 8572874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of EXP3174, an angiotensin II antagonist and enalaprilat on myocardial infarct size in anaesthetized dogs.
    Richard V; Ghaleh B; Berdeaux A; Giudicelli JF
    Br J Pharmacol; 1993 Nov; 110(3):969-74. PubMed ID: 8298820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal effects of angiotensin II receptor blockade and angiotensin-converting enzyme inhibition in healthy subjects.
    Burnier M; Brunner HR
    Exp Nephrol; 1996; 4 Suppl 1():41-6. PubMed ID: 9001896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular hypertrophy in one-kidney, one clip renal hypertensive rats: a role for angiotensin II?
    O'Sullivan JB; Black MJ; Bertram JF; Bobik A
    J Hypertens; 1994 Oct; 12(10):1163-70. PubMed ID: 7836732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.
    Siegl PK; Chang RS; Mantlo NB; Chakravarty PK; Ondeyka DL; Greenlee WJ; Patchett AA; Sweet CS; Lotti VJ
    J Pharmacol Exp Ther; 1992 Jul; 262(1):139-44. PubMed ID: 1625193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.